Development of a melting tablet containing promethazine HCl against motion sickness

AAPS PharmSciTech

Volumn 9, Issue 3, 2008, Pages 1006-1015

  Haware, Rahul V ^a   Chaudhari, P D ^b   Parakh, S R ^c   Bauer Brandl, A ^a  

^a UNIVERSITY OF TROMSØ   (Norway)

^b DR D Y PATIL INSTITUTE OF PHARMACEUTICAL SCIENCES AND RESEARCH   (India)

^c MAEER S MAHARASHTRA INSTITUTE OF PHARMACY   (India)

Author keywords

Eudragit E 100; Eudragit RD 100; Promethazine hydrochloride; Rapidly disintegrating tablet; Stability study; Superdisintegrants

Indexed keywords

AEROSIL; CROSCARMELLOSE SODIUM; CROSPOVIDONE; EUDRAGIT; MAGNESIUM STEARATE; MANNITOL; MICROCRYSTALLINE CELLULOSE; POLACRILIN; PROMETHAZINE; STARCH GLYCOLATE SODIUM; VANILLIN;

ARTICLE; BITTER TASTE; COMPLEX FORMATION; CONTROLLED RELEASE FORMULATION; DRUG DOSAGE FORM COMPARISON; DRUG SOLUBILITY; HUMAN; HUMAN EXPERIMENT; IN VITRO STUDY; IN VIVO STUDY; MOTION SICKNESS; NORMAL HUMAN; TABLET COMPRESSION; TABLET DISINTEGRATION TIME; TABLET FORMULATION; TABLET FRIABILITY; TABLET HARDNESS; TENSILE STRENGTH; WATER ABSORPTION;

ADMINISTRATION, ORAL; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; DRUG DESIGN; DRUG STABILITY; HARDNESS; HUMANS; MOTION SICKNESS; POWDERS; PROMETHAZINE; SOLUBILITY; TABLETS; TASTE PERCEPTION;

EID: 57149138423     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9133-x     Document Type: Article

References (21)

1. R.-K. Chang, X. Guo, B. A. Burnside, and R. A. Couch. Fast-dissolving tablets. Pharm. Technol. 24 6:52, 54, 56, 58 (2000).
2. Guidance for Industry Orally Disintegrating Tablet. http://www.fda.gov/ cder/guidance/5909dft.htm. Accessed March 3, 2008.
3. J. N. Delgado. Histaminics and Antihistaminics. In W. Grisvold (ed.), In Text Book Of Organic Medical and Pharmaceutical Chemistry, 11th ed., Lippincott, Philadelphia, 1998, pp. 710-711.
4. Bitterness value. European Pharmacopoeia, 5th ed., Council of Europe, Strasbourg, 2004, pp. 221-223.
5. GmbH R. Eudragit®: Polymethacrylate for phatmaceutical use, Technical literature. Darmstadt, Germany.
6. T. Ishikawa, Y. Watanabe, N. Utoguchi, and M. Matsumoto. Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter-taste-masked granules by the compression method. Chem. Pharm. Bull. (Tokyo). 47 10:1451-1454 (1999)Oct.
7. Y. Shirai, K. Sogo, H. Fujioka, and Y. Nakamura. Influence of heat treatment on dissolution and masking degree of bitter taste for a novel fine granule system. Chem. Pharm. Bul. 44 2:399-402 (1996).
8. W. A. Ritschel, and A. Bauer-Brandl. Herstellung verpreβbarer tablettiermessen. Die Tablette Handbuch der Entwicklung, Herstellung und Qualitätssicherung. Editio Cantor, Aulendorf, 2002, p. 355.
9. Uniformity of mass of single dose preparations. European pharmacopoeia, 233 (2004).
10. Friability of uncoated tablets. European Pharmacopoeia. 5th ed. Council of Europe, Strasbourg, 2004, p. 3103.
11. J. M. Newton, G. Rowley, J. T. Fell, D. G. Peacock, and K. Ridgway. Computer analysis of the relation between tablet strength and compaction pressure. J. Pharm. Pharmacol. 23 Suppl.:195S-201S (1971).
12. Uniformity of drug content. Indian Pharmacopoeia, vol 2. 4th ed. Controller of Publication, Government of India, New-Delhi, 1996, pp. 734-736.
13. Y. Bi, H. Sunada, Y. Yonezawa, K. Danjo, A. Otsuka, and K. Iida. Preparation and evaluation of a compressed tablet rapidly disintegrating in the oral cavity. Chem. Pharm. Bull. (Tokyo). 44 11:2121-2127 (1996)Nov.
14. Disintegration of tablets and capsules. European Pharmacopoeia. 5th ed. Council of Europe, Strasbourg, 2004, pp. 3351-3353.
15. The United States Pharmacopoeia-27/National Formulary-22. Asia Edition ed. Rockville MD, 2000, pp. 1572-1573.
16. B. R. Matthews. Regulatory aspects of stability testing in Europe. Drug Dev. Ind. Pharm. 25 7:831-856 (1999)Jul.
17. L. B. A. Augsburger, U. Shah, and H. Hahm. Super disintegrants: Characterization and function. In J. Swarbrick, and J. C. Boylan (eds.), Encyclopedia of Pharmaceutical Technology, vol 20, Marcel Dekker, New York, 2001, pp. 269-290.
18. Y. X. Bi, H. Sunada, Y. Yonezawa, and K. Danjo. Evaluation of rapidly disintegrating tablets prepared by a direct compression method. Drug Dev. Ind. Pharm. 25 5:571-581 (1999)May.
19. A. H. Kibbe. Handbook of Pharmaceutical Excipients, 3rd ed., Pharmaceutical, Washington, 2000.
20. Phenergan. http://www.rxlist.com/cgi/generic/prometh.htm Accessed March 3, 2007.
21. International Conference on Harmonisation of Technical Requirement for Registration of Pharmaceuticals for Human Use. http://www.ich.org/LOB/ media/MEDIA419.pdf. Accessed March 3, 2007.